Darian Bartkowski

Darian Bartkowski

Takeda Pharmaceutical Company Limited - Osaka / Japan
Others
AD Scientific Index ID: 4404375
武田薬品工業株式会社
person_outline Darian Bartkowski's MOST POPULAR ARTICLES
1-) Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve functionY Du, J Tang, G Li, L Berti-Mattera, CA Lee, D Bartkowski, D Gale, ...Investigative ophthalmology & visual science 51 (4), 2158-2164, 20101252010
2-) Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood–brain barrierA Rohner, ME Spilker, JL Lam, B Pascual, D Bartkowski, QJ Li, AH Yang, ...Molecular cancer therapeutics 11 (1), 57-65, 2012542012
3-) Discovery of tricyclic 5, 6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymeraseF Ruebsam, DE Murphy, CV Tran, LS Li, J Zhao, PS Dragovich, ...Bioorganic & medicinal chemistry letters 19 (22), 6404-6412, 2009462009
4-) Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribineAX Xiang, SE Webber, BM Kerr, EJ Rueden, JR Lennox, GJ Haley, ...Nucleosides, Nucleotides, and Nucleic Acids 26 (6-7), 635-640, 2007462007
5-) Pyrrolo [1, 2-b] pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseF Ruebsam, SE Webber, MT Tran, CV Tran, DE Murphy, J Zhao, ...Bioorganic & medicinal chemistry letters 18 (12), 3616-3621, 2008422008